ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Dicyclohexylcarbodiimide → t-Butyldimethylsilyl 6-O-{3-O-allyloxycarbonyl-6-O-benzyl-2-deoxy-4-O-(1,5-dihydro-3-oxo-3lambda5-3H-2,4,3-benzodioxaphosphepin-3yl)-2-[(R)-3-dodecanoyloxy-tetradecanoylamino]-beta-D-glucopyranosyl}-2-azido-4-O-benzyl-3-O-[(R)-3-benzyloxy-dodecanoyl]-2-deoxy-beta-D-glucopyranoside

HRID 628195
ノート
印刷プレビュー

反応式

HRID 628195 の反応式
[CH2:1]([O:8][C@H:9]([CH2:14][CH2:15][CH2:16][CH2:17][CH2:18][CH2:19][CH2:20][CH2:21][CH3:22])[CH2:10][C:11]([OH:13])=[O:12])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C1CCC(N=C=NC2CCCCC2)CC1.[CH2:38]([O:41][C:42]([O:44][C@H:45]1[C@H:50]([O:51][P:52]2(=[O:63])[O:58][CH2:57][C:56]3[CH:59]=[CH:60][CH:61]=[CH:62][C:55]=3[CH2:54][O:53]2)[C@@H:49]([CH2:64][O:65][CH2:66][C:67]2[CH:72]=[CH:71][CH:70]=[CH:69][CH:68]=2)[O:48][C@@H:47]([O:73][CH2:74][C@H:75]2[O:88][C@@H:79]([O:80][Si:81]([C:84]([CH3:87])([CH3:86])[CH3:85])([CH3:83])[CH3:82])[C@H:78]([N:89]=[N+:90]=[N-:91])[C@@H:77](O)[C@@H:76]2[O:93][CH2:94][C:95]2[CH:100]=[CH:99][CH:98]=[CH:97][CH:96]=2)[C@@H:46]1[NH:101][C:102](=[O:130])[CH2:103][C@H:104]([O:116][C:117](=[O:129])[CH2:118][CH2:119][CH2:120][CH2:121][CH2:122][CH2:123][CH2:124][CH2:125][CH2:126][CH2:127][CH3:128])[CH2:105][CH2:106][CH2:107][CH2:108][CH2:109][CH2:110][CH2:111][CH2:112][CH2:113][CH2:114][CH3:115])=[O:43])[CH:39]=[CH2:40]>C(Cl)Cl.CN(C1C=CN=CC=1)C>[CH2:38]([O:41][C:42]([O:44][C@H:45]1[C@H:50]([O:51][P:52]2(=[O:63])[O:58][CH2:57][C:56]3[CH:59]=[CH:60][CH:61]=[CH:62][C:55]=3[CH2:54][O:53]2)[C@@H:49]([CH2:64][O:65][CH2:66][C:67]2[CH:68]=[CH:69][CH:70]=[CH:71][CH:72]=2)[O:48][C@@H:47]([O:73][CH2:74][C@H:75]2[O:88][C@@H:79]([O:80][Si:81]([C:84]([CH3:85])([CH3:87])[CH3:86])([CH3:82])[CH3:83])[C@H:78]([N:89]=[N+:90]=[N-:91])[C@@H:77]([O:12][C:11](=[O:13])[CH2:10][C@H:9]([O:8][CH2:1][C:2]3[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=3)[CH2:14][CH2:15][CH2:16][CH2:17][CH2:18][CH2:19][CH2:20][CH2:21][CH3:22])[C@@H:76]2[O:93][CH2:94][C:95]2[CH:96]=[CH:97][CH:98]=[CH:99][CH:100]=2)[C@@H:46]1[NH:101][C:102](=[O:130])[CH2:103][C@H:104]([O:116][C:117](=[O:129])[CH2:118][CH2:119][CH2:120][CH2:121][CH2:122][CH2:123][CH2:124][CH2:125][CH2:126][CH2:127][CH3:128])[CH2:105][CH2:106][CH2:107][CH2:108][CH2:109][CH2:110][CH2:111][CH2:112][CH2:113][CH2:114][CH3:115])=[O:43])[CH:39]=[CH2:40]
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 3

HCID 10868DicyclohexylcarbodiimideHCID 16216230t-Butyldimethylsilyl 6-O-{3-O-allyloxycarbonyl-6-O-benzyl-2-deoxy-4-O-(1,5-dihydro-3-oxo-3lambda5-3H-2,4,3-benzodioxaphosphepin-3yl)-2-[(R)-3-dodecanoyloxy-tetradecanoylamino]-beta-D-glucopyranosyl}-2-azido-4-O-benzyl-2-deoxy-beta-D-glucopyranosideHCID 67004404(r)-3-Benzyloxy-dodecanoic acid

生成物 1

HCID 87233474
t-Butyldimethylsilyl 6-O-{3-O-allyloxycarbonyl-6-O-benzyl-2-deoxy-4-O-(1,5-dihydro-3-oxo-3lambda5-3H-2,4,3-benzodioxaphosphepin-3yl)-2-[(R)-3-dodecanoyloxy-tetradecanoylamino]-beta-D-glucopyranosyl}-2-azido-4-O-benzyl-3-O-[(R)-3-benzyloxy-dodecanoyl]-2-deoxy-beta-D-glucopyranoside
収率 91%

試薬・触媒・溶媒 2

HCID 142844-(Dimethylamino)pyridine触媒HCID 6344Dichloromethane溶媒2 回

実験手順

A solution of (R)-3-benzyloxy-dodecanoic acid 14 (86 mg, 0.281 mmol) and DCC (78 mg, 0.376 mmol) in DCM (5 mL) was stirred at room temperature for 10 min, and then disaccharide 21 (250 mg, 0.188 mmol) in DCM (2 mL) and DMAP (11 mg, 0.094 mmol) were added. The reaction mixture was stirred for another 14 h, after which the solids were removed by filtration, and the residue was washed with DCM (2×1 mL). The combined filtrates were concentrated in vacuo, and the residue was purified by silica gel column chromatography (hexane/ethyl acetate, 4/1, v/v) to give 36 as a white solid (277 mg, 91%). Rf=0.41 (hexane/ethyl acetate, 2/1, v/v). [α]26D=−3.0° (c=1.0, CHCl3). 1H NMR (600 MHz, CDCl3): δ 7.34-7.15 (m, 19H, aromatic), 6.01 (d, 1H, JNH′,2=7.2 Hz, NH′), 5.92-6.86 (m, 1H, OCH2CH═CH2), 5.46 (t, 1H, J2′,3′=J3′,4′=9.6 Hz, H-3′), 5.34 (d, 1H, J=16.8 Hz, OCH2CH═CH2), 5.22 (d, 1H, J=10.8 Hz, OCH2CH═CH2), 5.08-4.97 (m, 7H, H-1′, H-3, H-3L, C6H4(CH2O)2P), 4.61-4.45 (m, 10H, H-1, H-4′, 3×CH2Ph, OCH2CH═CH2), 3.97 (d, 1H, J6′a,6′b=10.5 Hz, H-6′a), 3.88-3.86 (m, 1H, H-3S), 3.81 (d, 1H, J6a,6b=9.5 Hz, H-6a), 3.73-3.68 (m, 3H, H-5′, H-6b, H-6′b), 3.56-3.46 (m, 3H, H-2′, H-4, H-5), 3.28 (dd, 1H, J1,2=7.8 Hz, J2,3=10.2 Hz, H-2), 2.56 (dd, 1H, J2Sa,2Sb=15.6 Hz, J2Sa,3S=7.2 Hz, H-2Sa), 2.44 (dd, 1H, J2Sa,2Sb=15.6 Hz, J2Sb,S3=6.0 Hz, H-2Sb), 2.36 (dd, 1H, J2La,2Lb=15.0 Hz, J2La,3 L=6.0 Hz, H-2La), 2.30-2.21 (m, 3H, H-2L′, H-2L′b), 1.57-1.53 (m, 6H, H-4L, H-4S, H-3L′), 1.24 (broad, 48H, 24×CH2, lipid), 0.90 (s, 9H, SiC(CH3)3), 0.89-0.85 (m, 9H, 3×CH3, lipid), 0.13 (s, 6H, Si(CH3)2). 13C NMR (75 MHz, CDCl3): δ 173.54 (C═O), 170.64 (C═O), 170.03 (C═O), 154.49 (C═O), 138.52-127.43 (aromatic, OCH2CH═CH2), 118.84 (OCH2CH═CH2), 99.34 (C-1′), 97.02 (C-1), 76.00, 75.70, 74.33, 74.08, 73.73, 73.48, 71.46, 71.01, 68.95-67.99 (m), 66.55, −4.13 (Si(CH3)2), −5.32 (Si(CH3)2). HR MS (m/z) calculated for C89H135N4O19PSi [M+Na], 1645.9125. found, 1646.2435.

後処理

  1. customafter which the solids were removed by filtration
  2. washthe residue was washed with DCM (2×1 mL)
  3. concentrationThe combined filtrates were concentrated in vacuo
  4. customthe residue was purified by silica gel column chromatography (hexane/ethyl acetate, 4/1

出典と根拠

ORDレコード
ord-ca21e0a3ae64460a82af848b7d7c58ea
出典データセット
uspto-grants-2016_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09309276B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート